Toronto, Ontario–(Newsfile Corp. – February 25, 2021) – PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (“ PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce it has expanded its psychedelic…


Previous articleNova Mentis Autism Clinical Study Approved by Institutional Review Board
Next article‘One-of-a-Kind’ $10 Million Psychedelic Research Center Comes to NYU